Concordia Healthcare acquires legacy pharmaceutical products and acquires and develops orphan drugs.
Concordia is focused on acquiring Specialty Healthcare and Pharmaceutical Distribution companies.
Concordia Healthcare is listed on the TSX Exchange under (TSX:CXR).
April 3, 2014
Concordia Healthcare (TSX: CXR) CEO Mark Thompson appeared on BNN’s The Street “Stock in the ...
April 1, 2014
Innovative approach for treating recurrent head/neck cancer borrows techniques from radiation medicine ...